BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 23782330)

  • 1. Bi-directional roles of bone morphogenetic proteins in cancer: another molecular Jekyll and Hyde?
    Ehata S; Yokoyama Y; Takahashi K; Miyazono K
    Pathol Int; 2013 Jun; 63(6):287-96. PubMed ID: 23782330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.
    Jiramongkolchai P; Owens P; Hong CC
    Biochem Soc Trans; 2016 Aug; 44(4):1117-34. PubMed ID: 27528760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway.
    Katsuno Y; Hanyu A; Kanda H; Ishikawa Y; Akiyama F; Iwase T; Ogata E; Ehata S; Miyazono K; Imamura T
    Oncogene; 2008 Oct; 27(49):6322-33. PubMed ID: 18663362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone morphogenetic proteins in tumour associated angiogenesis and implication in cancer therapies.
    Ye L; Jiang WG
    Cancer Lett; 2016 Oct; 380(2):586-597. PubMed ID: 26639195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone morphogenetic proteins and cancer: review of the literature.
    Thawani JP; Wang AC; Than KD; Lin CY; La Marca F; Park P
    Neurosurgery; 2010 Feb; 66(2):233-46; discussion 246. PubMed ID: 20042986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
    J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenetic proteins in breast cancer: dual role in tumourigenesis?
    Alarmo EL; Kallioniemi A
    Endocr Relat Cancer; 2010 Jun; 17(2):R123-39. PubMed ID: 20335308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor β and bone morphogenetic protein actions in brain tumors.
    Caja L; Bellomo C; Moustakas A
    FEBS Lett; 2015 Jun; 589(14):1588-97. PubMed ID: 25957771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone morphogenetic proteins mediate crosstalk between cancer cells and the tumour microenvironment at primary tumours and metastases (Review).
    Sun Z; Cai S; Zabkiewicz C; Liu C; Ye L
    Int J Oncol; 2020 Jun; 56(6):1335-1351. PubMed ID: 32236571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte growth factor up-regulates the expression of the bone morphogenetic protein (BMP) receptors, BMPR-IB and BMPR-II, in human prostate cancer cells.
    Ye L; Lewis-Russell JM; Davies G; Sanders AJ; Kynaston H; Jiang WG
    Int J Oncol; 2007 Feb; 30(2):521-9. PubMed ID: 17203235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMP modulators regulate the function of BMP during body patterning and disease progression.
    Yanagita M
    Biofactors; 2009; 35(2):113-9. PubMed ID: 19449438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMP signaling and its paradoxical effects in tumorigenesis and dissemination.
    Zhang L; Ye Y; Long X; Xiao P; Ren X; Yu J
    Oncotarget; 2016 Nov; 7(47):78206-78218. PubMed ID: 27661009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of RUNX3 in bone morphogenetic protein signaling in colorectal cancer.
    Lee CW; Ito K; Ito Y
    Cancer Res; 2010 May; 70(10):4243-52. PubMed ID: 20442291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [BMP and cancer: the Yin and Yang of stem cells].
    Sagorny K; Chapellier M; Laperrousaz B; Maguer-Satta V
    Med Sci (Paris); 2012 Apr; 28(4):416-22. PubMed ID: 22549870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling.
    Peng Y; Kang Q; Cheng H; Li X; Sun MH; Jiang W; Luu HH; Park JY; Haydon RC; He TC
    J Cell Biochem; 2003 Dec; 90(6):1149-65. PubMed ID: 14635189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts).
    Bessa PC; Casal M; Reis RL
    J Tissue Eng Regen Med; 2008 Jan; 2(1):1-13. PubMed ID: 18293427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of action of bone morphogenetic proteins in cancer.
    Davis H; Raja E; Miyazono K; Tsubakihara Y; Moustakas A
    Cytokine Growth Factor Rev; 2016 Feb; 27():81-92. PubMed ID: 26678814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular BMP-antagonist regulation in development and disease: tied up in knots.
    Walsh DW; Godson C; Brazil DP; Martin F
    Trends Cell Biol; 2010 May; 20(5):244-56. PubMed ID: 20188563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone morphogenetic proteins and their receptor signaling in prostate cancer.
    Ye L; Lewis-Russell JM; Kyanaston HG; Jiang WG
    Histol Histopathol; 2007 Oct; 22(10):1129-47. PubMed ID: 17616940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunolocalization of BMPs, BMP antagonists, receptors, and effectors during fracture repair.
    Yu YY; Lieu S; Lu C; Miclau T; Marcucio RS; Colnot C
    Bone; 2010 Mar; 46(3):841-51. PubMed ID: 19913648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.